Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris T. Bikbov, Caroline A. Purcell, Andrew S. Levey, Mari Smith, Amir Abdoli, Molla Abebe, Oladimeji Adebayo, Mohsen Afarideh, Sanjay Kumar Agarwal, Marcela Agudelo‐Botero, Elham Ahmadian, Ziyad Al‐Aly, Vahid Alipour, Amir Almasi‐Hashiani, Rajaa Mohammad Al-Raddadi, Nelson Alvis‐Guzmán, Tudorel Andrei, Cătălina Liliana Andrei, Zewudu Andualem, Mina Anjomshoa, Jalal Arabloo, Alebachew Fasil, Daniel Asmelash, Zerihun Ataro, Maha Moh’d Wahbi Atout, Martin Amogre Ayanore, Alaa F. Badawi, Ahad Bakhtiari, Shoshana H. Ballew, Abbas Balouchi, Maciej Banach, Símón Barquera, Sanjay Basu, Mulat Tirfie Bayih, Neeraj Bedi, Aminu K. Bello, Isabela M. Benseñor, Ali Bijani, Archith Boloor, Antonio Maria Borzì, Luis Alberto Cámera, Juan Jesús Carrero, Félix Dias Carvalho, Franz Castro, Ferrán Catalá-López, Alex R. Chang, Ken Lee Chin, Sheng‐Chia Chung, Massimo Círillo, Ewerton Cousin, Lalit Dandona, Rakhi Dandona, Ahmad Daryani, Rajat Das Gupta, Feleke Mekonnen Demeke, Gebre Teklemariam Demoz, Desilu Mahari Desta, Huyen Phuc Do, Bruce Bartholow Duncan, Aziz Eftekhari, Alireza Esteghamati, Syeda Sadia Fatima, João Carlos Fernandes, Eduarda G. R. Fernandes, Florian Fischer, Marisa Freitas, Mohamed M. Gad, Gebreamlak Gebremedhn Gebremeskel, Begashaw Melaku Gebresillassie, Birhanu Geta, Mansour Ghafourifard, Alireza Ghajar, Nermin Ghith, Paramjit Singh Gill, Ibrahim Ginawi, Nima Hafezi‐Nejad, Arvin Haj‐Mirzaian, Arya Haj‐Mirzaian, Ninuk Hariyani, Md. Mehedi Hasan, Milad Hasankhani, Amir Hasanzadeh, Hamid Yimam Hassen, Simon Iain Hay, Behnam Heidari, Claudiu Herţeliu, Chi Linh Hoang, Mostafa Hosseini, Mihaela Hostiuc, Seyed Sina Naghibi Irvani, Sheikh Mohammed Shariful Islam, Nader Jafari Balalami, Spencer Lewis James, Simerjot Kaur Jassal, Vivekanand Jha, Jost B Jonas, Farahnaz Joukar, Jacek Jerzy Jozwiak
The Lancet · 2020 · 7,282 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Bikbov, B. T., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O., Afarideh, M., Agarwal, S. K., Agudelo‐Botero, M., Ahmadian, E., Al‐Aly, Z., Alipour, V., Almasi‐Hashiani, A., Al-Raddadi, R. M., Alvis‐Guzmán, N., Amini, S., Andrei, T., Andrei, C. L., … Jozwiak, J. J. (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet, 395(10225), 709–733. https://doi.org/10.1016/s0140-6736(20)30045-3
In text: (Bikbov et al., 2020)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. METHODS: The main data sources we used were published literature, vital registration systems, end-stage kidney disease registries, and household surveys. Estimates of CKD burden were produced using a Cause of Death Ensemble model and a Bayesian meta-regression analytical tool, and included incidence, prevalence, years lived with disability, mortality, years of life lost, and disability-adjusted life-years (DALYs). A comparative risk assessment approach was used to estimate the proportion of cardiovascular diseases and gout burden attributable to impaired kidney function. FINDINGS: Globally, in 2017, 1·2 million (95% uncertainty interval [UI] 1·2 to 1·3) people died from CKD. The global all-age mortality rate from CKD increased 41·5% (95% UI 35·2 to 46·5) between 1990 and 2017, although there was no significant change in the age-standardised mortality rate (2·8%, -1·5 to 6·3). In 2017, 697·5 million (95% UI 649·2 to 752·0) cases of all-stage CKD were recorded, for a global prevalence of 9·1% (8·5 to 9·8). The global all-age prevalence of CKD increased 29·3% (95% UI 26·4 to 32·6) since 1990, whereas the age-standardised prevalence remained stable (1·2%, -1·1 to 3·5). CKD resulted in 35·8 million (95% UI 33·7 to 38·0) DALYs in 2017, with diabetic nephropathy accounting for almost a third of DALYs. Most of the burden of CKD was concentrated in the three lowest quintiles of Socio-demographic Index (SDI). In several regions, particularly Oceania, sub-Saharan Africa, and Latin America, the burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected. 1·4 million (95% UI 1·2 to 1·6) cardiovascular disease-related deaths and 25·3 million (22·2 to 28·9) cardiovascular disease DALYs were attributable to impaired kidney function. INTERPRETATION: Kidney disease has a major effect on global health, both as a direct cause of global morbidity and mortality and as an important risk factor for cardiovascular disease. CKD is largely preventable and treatable and deserves greater attention in global health policy decision making, particularly in locations with low and middle SDI. FUNDING: Bill & Melinda Gates Foundation.
Related papers
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
- Global Prevalence of Diabetes2004
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162017
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–20192020
Metadata from OpenAlex (CC0). Citations are generated from the published record.